Grapevine, TX · Medical Weight Loss

Medical Weight Loss in Grapevine, TX

GLP-1 programs with semaglutide and tirzepatide — medically supervised for safe, consistent results.

Treatment Overview

GLP-1 & Semaglutide Weight Loss

Dr. Lift Spa offers medically supervised weight loss programs in Grapevine, TX for eligible patients seeking safe, consistent, and long-term results. Our programs are built around GLP-1 receptor agonist medications — including semaglutide and tirzepatide — which have demonstrated significant clinical efficacy for weight management.

GLP-1 medications work by regulating appetite, slowing digestion, and improving insulin sensitivity — helping you consume less without the constant struggle of willpower. Combined with lifestyle guidance, these programs support sustainable fat loss that goes beyond what diet and exercise alone can achieve for many patients.

Our clinical team manages your program from initial consultation through ongoing monitoring, dose adjustments, and progress check-ins. We prioritize safety, transparency, and results. All prescriptions are issued and managed by licensed medical professionals.

Serving patients seeking medical weight loss near Grapevine, Southlake, Colleyville, Coppell, and the broader DFW area.

Book a Weight Loss Consultation

Common Questions

Medical Weight Loss FAQ — Grapevine, TX

Medical weight loss programs using GLP-1 medications are generally appropriate for adults with a BMI of 27 or higher with a weight-related condition, or a BMI of 30 or higher. A consultation with our clinical team will review your health history, goals, and eligibility for prescription-based support.
Semaglutide is a GLP-1 receptor agonist that works by mimicking a hormone your body naturally produces after eating. It slows gastric emptying, reduces appetite, and helps regulate blood sugar — making it easier to maintain a calorie deficit without constant hunger. It is administered as a weekly injection.
Both are GLP-1 based medications used for weight management. Tirzepatide (GIP/GLP-1 dual agonist) targets two receptors and has shown greater average weight loss in clinical studies. Our team will help determine which medication is most appropriate for your individual profile and health history.
Results vary based on starting weight, lifestyle, adherence, and individual metabolism. Clinical studies show average weight loss of 15–22% of body weight over 68–72 weeks with GLP-1 medications combined with dietary guidance. Our program includes monitoring and support to maximize your outcomes.

More questions? View all Weight Loss FAQ →

Ready to Start?

Book Your Weight Loss Consultation

Medically supervised programs. Semaglutide and tirzepatide available for eligible patients.

Book an Appointment
Book Now